Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)
Clinical trial NCT00443209 · COMPLETED
Trial details
- NCT number
- NCT00443209
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-21
- Primary completion
- 2009-01-22
- Enrollment
- 1068
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.